Here are four takeaways:
1. Prohesion is an activated type I collagen wound filler indicated for surgical wound management.
2. The technology is patented and uses type I collagen fragments that have been sheared down to an optimal size.
3. It is in a powder format that allows for complete and liberal coverage of surgical wounds.
4. BioStructures is focused on developing proprietary platforms in bioresorbable bone graft products for a number of spinal and orthopedic fusion procedures.
More articles on devices:
5 things to know about ApiFix’s new board chairman Ted Bird
Mazor appoints Chad Zaring vice president of national accounts — 5 key notes
SpineGuard launches public offering, buoys growth strategy — 8 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
